Evidence map›Paper›PMID 38155861›Full record

ArticleThe journal of allergy and clinical immunology. Global2024

Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis.

Yoshiaki Kobayashi, Keisuke Suzuki, Minoru Tateno, Yuki Nakamura, Kayoko Ishimaru, Yuka Nagasaka, Daiju Sakurai, Katsuyo Ohashi-Doi, Atsuhito Nakao

Open access · goldAbstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yoshiaki KobayashiDepartment of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Keisuke SuzukiTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Minoru TatenoTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Yuki NakamuraDepartment of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Kayoko IshimaruDepartment of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Yuka NagasakaDepartment of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Daiju SakuraiDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Yamanashi, Yamanashi, Japan.
Katsuyo Ohashi-DoiTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Atsuhito NakaoDepartment of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
University of Yamanashi · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Japan, pollinosis caused by the Japanese cypress (JCy) Objective: This study aimed to clarify the allergenicity of Cha o 3 compared with that of Cha o 1 and Cha o 2 in JCy pollinosis. Methods: We recruited 27 patients with JCy pollinosis and performed the basophil activation test (BAT) with native (n) Cha o 1, Cha o 2, and Cha o 3 purified from JCy pollen. In addition, we a performed JCy-specific IgE suppression test. Results: In the BAT, 26 of 27 patients (96%) and 18 of 27 patients (67%) showed positive basophil activation in response to n Cha o 1 and n Cha o 2, respectively, as judged by CD203c expression. Little CD203c expression in response to n Cha o 3 was seen. The presence of n Cha o 3 marginally reduced the titer levels of JCy-specific IgE. Conclusion: Cha o 3 showed little ability to activate basophils and suppress JCy-specific IgE titers compared with Cha o 1 or Cha o 2 in patients with JCy pollinosis. Thus, Cha o 3 may not be a major allergen in JCy pollinosis.

Indexed as

basophil activation testCha o 3Japanese cypress pollinosis

Identifiers

PMID38155861
PMCPMC10753085
OpenAlexW4389235780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.